Atreya Dash

发表

Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.

John T. Wei, M. Cooperberg, M. Meng, 2016, The Journal of urology.

Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer

S. Greenfield, T. Daskivich, M. Litwin, 2012, Journal of General Internal Medicine.

Disparities in Access and Regionalization of Care in Testicular Cancer

J. Gore, J. Wright, D. Lin, 2018, Clinical genitourinary cancer.

The Role of Postchemotherapy Surgery in Germ Cell Tumors.

A. Dash, L. Chery, L. Chéry, 2015, The Urologic clinics of North America.

TGF-β mediated DNA methylation in prostate cancer

M. Soares, Z. Jia, D. Mercola, 2012, Translational andrology and urology.

Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients.

Jose M Garcia, A. Dash, Lindsey J. Anderson, 2020, Clinical nutrition.

Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.

Ronglai Shen, Arul M Chinnaiyan, Mark A Rubin, 2002, The American journal of pathology.

Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.

M. Cooperberg, P. Carroll, J. Brooks, 2020, JAMA oncology.

Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder

A. Vickers, M. Galsky, B. Bochner, 2006, Cancer.

17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.

J. Brooks, P. Nelson, J. McKenney, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of readmission hospital on failure-to-rescue rates following major urologic cancer surgery.

J. Gore, J. Wright, S. Holt, 2017, Urologic oncology.

A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder

P. Russo, M. Milowsky, B. Bochner, 2008, Cancer.

The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance

J. Schenk, M. Neuhouser, C. Morrissey, 2024, Cancer.

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

I. Thompson, A. Kibel, Sam S. Chang, 2018, The Lancet.

Patency and Incontinence Rates After Robotic Bladder Neck Reconstruction for Vesicourethral Anastomotic Stenosis and Recalcitrant Bladder Neck Contractures: The Trauma and Urologic Reconstructive Network of Surgeons Experience.

A. Weinberg, S. Elliott, B. Breyer, 2018, Urology.

Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm

P. Russo, A. Vickers, A. Dash, 2006, BJU international.

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Christopher P. Filson, P. Carroll, J. Brooks, 2021, Cancer.

Whole‐body and adipose tissue metabolic phenotype in cancer patients

Yi-Ping Li, A. Dash, B. Anderson, 2022, Journal of cachexia, sarcopenia and muscle.

Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.

P. Febbo, J. Wright, B. Berse, 2017, The American journal of managed care.

Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.

M. Cooperberg, P. Carroll, J. Brooks, 2018, European urology.

Overtreatment of men with low‐risk prostate cancer and significant comorbidity

S. Greenfield, T. Daskivich, M. Litwin, 2011, Cancer.

Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort

P. Carroll, J. Brooks, J. McKenney, 2021, Urology practice.

Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling.

John T. Wei, R. Dunn, J. Montie, 2004, Urology.

Overtreatment of men with low‐risk prostate cancer and significant comorbidity

S. Greenfield, T. Daskivich, M. Litwin, 2011, Cancer.

Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence

D. Parekh, N. Smith, A. Shabsigh, 2022, JAMA network open.

Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)

B. Bochner, D. Bajorin, G. Dalbagni, 2007 .

Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.

S. Greenfield, T. Daskivich, M. Litwin, 2014, European urology.

Improved prediction of long-term, other cause mortality in men with prostate cancer.

Sheldon Greenfield, Mark S Litwin, Karim Chamie, 2011, The Journal of urology.

A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment

J. Schenk, Yingye Zheng, M. Neuhouser, 2016, Prostate Cancer and Prostatic Diseases.

Patient-centered risk stratification of disposition outcomes following radical cystectomy.

J. Gore, J. Wright, S. Holt, 2016, Urologic oncology.

Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Samuel K. Park, T. Ahlering, J. Fierer, 2014, The Journal of urology.

Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.

John Billimek, K. Osann, A. Dash, 2011, The Journal of urology.

Integrative analysis of genomic aberrations associated with prostate cancer progression.

S. Dhanasekaran, D. Ghosh, R. Shah, 2007, Cancer research.